VIVIMUSTA CONNECT Trademark

Trademark Overview


On Thursday, August 1, 2024, a trademark application was filed for VIVIMUSTA CONNECT with the United States Patent and Trademark Office. The USPTO has given the VIVIMUSTA CONNECT trademark a serial number of 98678514. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 18, 2025. This trademark is owned by Azurity Pharmaceuticals, Inc.. The VIVIMUSTA CONNECT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing patient support services in the nature of providing counseling and consulting in the field of healthcare insurance benefits; Providing patient support services in the nature of providing financial support to low-income patients for the purpose of obtaining medications; Providing financial support services in the nature of financial administration of medication reimbursement programs and medical treatment services

Providing patient support services in the nature of administration of a program for enabling participants to obtain discounts on the cost of medical treatments and medications

Providing medical information relating to oncological diseases and pharmaceuticals used to treat oncological diseases; Providing medical information; Administering medications to patients
vivimusta connect

General Information


Serial Number98678514
Word MarkVIVIMUSTA CONNECT
Filing DateThursday, August 1, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and ServicesProviding patient support services in the nature of providing counseling and consulting in the field of healthcare insurance benefits; Providing patient support services in the nature of providing financial support to low-income patients for the purpose of obtaining medications; Providing financial support services in the nature of financial administration of medication reimbursement programs and medical treatment services
Goods and ServicesProviding patient support services in the nature of administration of a program for enabling participants to obtain discounts on the cost of medical treatments and medications
Goods and ServicesProviding medical information relating to oncological diseases and pharmaceuticals used to treat oncological diseases; Providing medical information; Administering medications to patients

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 12, 2025
Primary Code035
First Use Anywhere DateTuesday, January 2, 2024
First Use In Commerce DateTuesday, January 2, 2024

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 1, 2024
Primary Code036
First Use Anywhere DateTuesday, January 2, 2024
First Use In Commerce DateTuesday, January 2, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 1, 2024
Primary Code044
First Use Anywhere DateTuesday, January 2, 2024
First Use In Commerce DateTuesday, January 2, 2024

Trademark Owner History


Party NameAzurity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events


Event DateEvent Description
Thursday, August 1, 2024NEW APPLICATION ENTERED
Wednesday, January 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2025ASSIGNED TO EXAMINER
Friday, February 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 21, 2025NON-FINAL ACTION WRITTEN
Friday, February 21, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 12, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 19, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED